期刊文献+

冠心病患者超敏C反应蛋白与白介素-11水平相关性分析

Correlation study between the circulation level of high sensitivity C-reactive protein(hs-CRP) and IL-11 in patients with coronary heart disease
暂未订购
导出
摘要 目的探讨冠心病患者超敏C反应蛋白(hs-CRP)与白介素-11(IL-11)的关系。方法将82例冠心病患者,根据冠状动脉造影结果分为4组:稳定型心绞痛(SA)组16例,不稳定型心绞痛(UA)组24例,急性心肌梗死(AMI)组22例,对照组20例。测定所有研究对象血浆hs-CRP、血清IL-11的水平。结果对照组、SA组、UA组及AMI组hs-CRP水平呈逐渐增高的趋势,而IL-11的水平呈逐渐降低的趋势,两者线性负相关。结论 IL-11水平的降低可能是冠状动脉粥样硬化患者斑块形成的原因之一。 Objective To explore the relationship between the circulation level of high sensitivity C - reactive protein ( hs - CRP) and soluble IL - 11 in patients with heart disease. Methods A clinical research wase accomplished in 82 patients who were diagnosed as coronary heart disease initially. Research objects were divided into four groups: 20 patients in the control group with negative result in coronary angiography, 16 patients in stable angina(SA) group, 24 patients in unstable angina(UA) group and 22 patients in acute myocardial infarction(AMI) group, hs - CRP and IL - 11 were measured in all of the objects. Results The plasma hs - CRP level were gradually rising from control group to AMI group and IL - 11 were gradually steping down. The level of hs - CRP and IL - 11 showed linear negative correlation. Conclusion The lower level of IL - 11 may be the one of reasons in plaque formation.
作者 段东杰
出处 《中国医学创新》 CAS 2009年第30期8-10,共3页 Medical Innovation of China
关键词 冠心病 超敏C反应蛋白 白介素-11 Coronary artery disease hs - CRP IL - 11
  • 相关文献

参考文献4

二级参考文献35

  • 1商安芳,郭静明,商建东,刘小慧,艾红,朱磊,曾一琴.重组人白介素11治疗前期再生障碍性贫血的血小板减少的初步观察[J].中国实验血液学杂志,2005,13(1):151-153. 被引量:10
  • 2李亚荣,夏大文,胡春梅,赵雷.白细胞介素-11治疗肿瘤化疗后血小板减少47例临床观察[J].中国肿瘤生物治疗杂志,2004,11(4):298-298. 被引量:4
  • 3张华,陶晓明,邓燕艺,李虎生.重组人白介素-11联合肾上腺皮质激素治疗特发性血小板减少性紫癜的临床观察[J].临床血液学杂志,2005,18(3):138-139. 被引量:13
  • 4Du X,Blood,1997年,89卷,3897页
  • 5Isaacs C,Robert NJ,Bailey FA,et al.Randomized placebo-controlled study of recombinant human interieukin-11 to prevent chemothrepy-induced thrimbo-cytopenia in patients with breasr cancer receiving dose-intensive cyclophosphamide and doxorubicin[J].Clin Oncol,1997,15:3 368-3 377.
  • 6Kurzrock R,Gortes J,Thomas DA,et al.Pilot study of lowdose interieukin-11 in patierus with bone marrow failure[J].Clin Oncol,2001,19:4 165-4 172.
  • 7Aoyama K,Uchida T,Takanuk F,et al.Pharmacokinetics of recombinant human interleukin-11 in healthy male subjects[J].Br J Clin Pharmacol,1997,43:571-578.
  • 8Gorcon MS,McCaskill-Stevens WJ,Battiato LA,et al.A phase I,trial of recombinant human interieukin-11(numega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy[J].Blood,1996,87(1):3 615-3 624.
  • 9Grosfeld JL,Du X,Willtanas DA.Interieukin-11:its bidogy and prospects for clinical use[J].Jpn J Parenter Enteral Nutr,1999,23(5 Suppl):S67 -S69.
  • 10Kurth I,Horsten U,Pflanz S,et al.Activation of the signal tansducer glycoprotein I 30 by both IL-6 and IL-11 reguires two distinc binding epitopes[J].J Immunol,1999,162:1 480-1 487.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部